133 related articles for article (PubMed ID: 8384875)
1. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.
Piccione E; Case RD; Domchek SM; Hu P; Chaudhuri M; Backer JM; Schlessinger J; Shoelson SE
Biochemistry; 1993 Apr; 32(13):3197-202. PubMed ID: 8384875
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
4. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.
Shoelson SE; Sivaraja M; Williams KP; Hu P; Schlessinger J; Weiss MA
EMBO J; 1993 Feb; 12(2):795-802. PubMed ID: 8382612
[TBL] [Abstract][Full Text] [Related]
5. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
[TBL] [Abstract][Full Text] [Related]
6. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
[TBL] [Abstract][Full Text] [Related]
7. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
8. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
9. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
11. A photoaffinity scan maps regions of the p85 SH2 domain involved in phosphoprotein binding.
Williams KP; Shoelson SE
J Biol Chem; 1993 Mar; 268(8):5361-4. PubMed ID: 7680644
[TBL] [Abstract][Full Text] [Related]
12. Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains.
Herbst JJ; Andrews G; Contillo L; Lamphere L; Gardner J; Lienhard GE; Gibbs EM
Biochemistry; 1994 Aug; 33(32):9376-81. PubMed ID: 7520748
[TBL] [Abstract][Full Text] [Related]
13. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
Rordorf-Nikolic T; Van Horn DJ; Chen D; White MF; Backer JM
J Biol Chem; 1995 Feb; 270(8):3662-6. PubMed ID: 7876105
[TBL] [Abstract][Full Text] [Related]
14. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.
Cooper JA; Kashishian A
Mol Cell Biol; 1993 Mar; 13(3):1737-45. PubMed ID: 8382774
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
16. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
17. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
18. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor.
Ponzetto C; Bardelli A; Maina F; Longati P; Panayotou G; Dhand R; Waterfield MD; Comoglio PM
Mol Cell Biol; 1993 Aug; 13(8):4600-8. PubMed ID: 7687741
[TBL] [Abstract][Full Text] [Related]
19. Phosphopeptide binding to the N-terminal SH2 domain of the p85 alpha subunit of PI 3'-kinase: a heteronuclear NMR study.
Hensmann M; Booker GW; Panayotou G; Boyd J; Linacre J; Waterfield M; Campbell ID
Protein Sci; 1994 Jul; 3(7):1020-30. PubMed ID: 7522724
[TBL] [Abstract][Full Text] [Related]
20. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
Songyang Z; Shoelson SE; McGlade J; Olivier P; Pawson T; Bustelo XR; Barbacid M; Sabe H; Hanafusa H; Yi T
Mol Cell Biol; 1994 Apr; 14(4):2777-85. PubMed ID: 7511210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
